Shaping Tomorrow: Singapore's Vision for Life Sciences, Biotech, and Medtech
Following the announcement of the government’s $500M investment to refresh the public biosciences and medtech research infrastructure in the greater one-north area, Singapore is preparing for a new phase of development for these industries.
This event, co-organised by The Singaporean-German Chamber of Industry and Commerce, The French Chamber of Commerce and Biotech Connection Singapore, will discuss the details behind this announcement and explore the opportunities it presents for companies and startups.
Industry experts will then discuss the next steps in Singapore’s journey—where future investments are headed, how emerging trends like biotech, precision medicine, and AI-driven healthcare will shape the landscape, and what this means for businesses, researchers, and entrepreneurs.
Key Discussion Points
- Budget allocations and their impact on life sciences
- Success stories: How past investments have fueled growth
- Future investment priorities and emerging opportunities
- Challenges and policy considerations for sustaining momentum
Speakers
- Prof. Huck Hui Ng, Assistant Chief Executive, Research and Talent Development at A*STAR
- Zainab Sadat, General Manager and Head of Vaccines for SEA & India at Sanofi
- EDB (speaker to be announced)
Moderator
- Maximilian Englisch, SGC Co-chair Healthcare & Life Sciences Committee, Global Vice-President of Sales at WALDNER Group
